Runway Growth Finance Corp. 7.25% Notes due 2031 (RWAYI)

Slow Grower

FairStock Score: 50/100 — MIXED

Key Financials

Current Price$24.77
Market Cap$1.0B
P/E Ratio—
ROE1.55%
Dividend Yield—%
SectorFinancial Services

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I am looking at a fixed-income claim on a business development company, not at the common equity. Runway Growth lends to late-stage growth companies, often in technology, life sciences, healthcare, and business services, and it says it prefers senior-secured loans. That gives it a lender's position, but the filed figures show an issuer whose profits are uneven. In FY2024, the company earned $73.6M; in FY2025, net income fell to $34.0M. In fiscal Q1 2026, the quarter ended 2026-03-31, it lost $34.8M, or $0.96 per diluted share. Then in fiscal Q2 2026, the quarter ended 2026-06-30, it rebounded to $27.2M, or $0.65 per diluted share. I do not call that a stable stream backing a fixed 7.25% coupon due 2031. The FairStock Lynch category is SLOW GROWER — Shrinking, with profit down about 6.2% a year over five years. FairStock calculations show a return on equity of only 1.55% and return on capital of 5.54%, while debt-to-equity is 1.38. The data lists a market cap of $1.0B and a price-to-book ratio of 2.05, but that is not a margin of safety for a noteholder. The notes last traded at $24.41 on 2026-10-13, near the low end of a 52-week range of $24.25 to $25.93, with a beta of 0.63. A 7.25% coupon is attractive only if the issuer's credit remains sound; the earnings volatility and low returns argue for caution, and the filed figures do not give me interest coverage or asset coverage to verify safety. I would need a clearer cushion before treating the coupon as dependable.

In plain English: Runway Growth Finance Corp. is a lender that focuses on secured loans to later-stage growth companies. Its profits have been uneven and have shrunk over the last five years, so the business looks only fair to weak. The 7.25% notes due 2031 last traded at $24.41 on 2026-10-13, near the bottom of their 52-week range, so the price does not look expensive but reflects that weaker profit picture.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer